Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway

被引:52
|
作者
Chen, Liming [1 ]
Loh, Portia Gloria [1 ]
Song, Haiwei [1 ,2 ,3 ]
机构
[1] ASTAR, Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore 138673, Singapore
[2] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore
[3] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore
关键词
Hippo; Yes-associated protein (YAP); transcription enhancer factor (TEAD); Yki; phosphorylation; crystal structure;
D O I
10.1007/s13238-010-0138-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The control of organ size growth is one of the most fundamental aspects of life. In the past two decades, a highly conserved Hippo signaling pathway has been identified as a key molecular mechanism for governing organ size regulation. In the middle of this pathway is a kinase cascade that negatively regulates the downstream component Yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ)/Yorkie through phosphorylation. Phosphorylation of YAP/TAZ/Yorkie promotes its cytoplasmic localization, leads to cell apoptosis and restricts organ size overgrowth. When the Hippo pathway is inactivated, YAP/TAZ/Yorkie trans-locates into the nucleus to bind to the transcription enhancer factor (TEAD/TEF) family of transcriptional factors to promote cell growth and proliferation. In this review, we will focus on the structural and functional studies on the downstream transcription factor TEAD and its coactivator YAP.
引用
收藏
页码:1073 / 1083
页数:11
相关论文
共 50 条
  • [41] The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass
    Sasaki, Hiroshi
    MECHANISMS OF DEVELOPMENT, 2009, 126 : S22 - S22
  • [42] Correlation between Hippo-YAP signaling pathway and liver cancer
    Ji, Y. B.
    Yu, W. J.
    Xin, G. S.
    He, J. X.
    2018 INTERNATIONAL CONFERENCE ON ZOOLOGY, BOTANY AND ECOLOGY (ICZBE 2018), 2019, : 17 - 20
  • [43] Hippo-YAP signaling pathway: A new paradigm for cancer therapy
    Ma, Yanlei
    Yang, Yongzhi
    Wang, Feng
    Wei, Qing
    Qin, Huanlong
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (10) : 2275 - 2286
  • [44] Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma
    Ouyang, Taohui
    Meng, Wei
    Li, Meihua
    Hong, Tao
    Zhang, Na
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2020, 40 (04) : 495 - 510
  • [45] Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck
    Santos-de-Frutos, Karla
    Segrelles, Carmen
    Lorz, Corina
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
  • [46] Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma
    Taohui Ouyang
    Wei Meng
    Meihua Li
    Tao Hong
    Na Zhang
    Cellular and Molecular Neurobiology, 2020, 40 : 495 - 510
  • [47] Hippo/TEAD4 signaling pathway as a potential target for the treatment of breast cancer
    Wu, Yujian
    Li, Mengjie
    Lin, Jiayi
    Hu, Chenxia
    ONCOLOGY LETTERS, 2021, 21 (04)
  • [48] A high-affinity Optide (optimized peptide) inhibitor of the Hippo pathway's YAP-TEAD interaction
    Crook, Zachary R.
    Bradley, Philip
    Sevilla, Gregory
    Friend, Della
    King, Chris
    Mhyre, Andrew
    Strong, Roland
    Baker, David
    Olson, James M.
    CANCER RESEARCH, 2017, 77
  • [49] Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma
    Shi, Hewen
    Zou, Ying
    Zhong, Weiwei
    Li, Zhaoying
    Wang, Xiaoxue
    Yin, Yancun
    Li, Defang
    Liu, Ying
    Li, Minjing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (16) : 15311 - 15322
  • [50] Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer
    Song, Ruolan
    Gu, Dongsheng
    Zhang, Lining
    Zhang, Xiaoli
    Yu, Beiqin
    Liu, Bingya
    Xie, Jingwu
    MOLECULAR CARCINOGENESIS, 2018, 57 (11) : 1608 - 1615